Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
371. |
ECCT/16/11/02 | IMPAACT P1093 Phase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of Dolutegravir, a Novel Integrase Inhibitor, in Combination Regimens in… read more |
Principal Investigator(s) 1. Lucy Koech Site(s) in Kenya KENYA MEDICAL RESEARCH INSTITUTE/WALTER REED PROJECT HIV PROGRAME |
View |
372. |
ECCT/16/10/02 | PAINT Study A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral-naïve HIV-1… read more |
Principal Investigator(s) 1. Professor Walter Jaoko Site(s) in Kenya 1. KAVI Institute of Clinical Research (Nairobi City county) 2. Kenya Medical… read more |
View |
373. |
ECCT/16/10/01 |
INVICTUS INVESTIGATION OF RHEUMATIC AF TREATMENT USING VITAMIN K ANTAGONISTS, RIVAROXABAN OR ASPRIN STUDIES |
Principal Investigator(s) 1. Elijah Nyainda Ogola 2. felix ayub barasa Site(s) in Kenya 1. Kenyatta National hospital (Nairobi City county) 2. Moi teaching… read more |
View |
374. |
ECCT/16/09/03 | Effect of Schistosoma mansoni infection on incidence of Plasmodium falciparum malaria among 1-5 year old children in western Kenya. Effect of Schistosoma mansoni infection on incidence… read more |
Principal Investigator(s) 1. Dr.Pauline NM Mwinzi Site(s) in Kenya KEMRI CGHR |
View |
375. |
ECCT/16/09/02 |
Monitoring Pre-Exposure Prophylaxis for Young Adult Women ( (MPYA) Next generation real-time monitoring for PrEP adherence in young adult women. |
Principal Investigator(s) 1. Prof. Elizabeth Anne Bukusi Bukusi 2. Dr. Stella Njuguna Njuguna Site(s) in Kenya 1. KISUMU SITE (Kisumu county) |
View |